|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 49/00 | (2006.01) |
| A61P 35/02 | (2006.01) | ||
| A61K 31/00 | (2006.01) | ||
| A61K 31/506 | (2006.01) |
| (11) | Number of the document | 2068938 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07842842.2 |
| Date of filing the European patent application | 2007-09-20 | |
| (97) | Date of publication of the European application | 2009-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2011-01-19 |
| (46) | Date of publication of the claims translation | 2011-05-25 |
| (86) | Number | PCT/US2007/078978 |
| Date | 2007-09-20 |
| (87) | Number | WO 2008/036792 |
| Date | 2008-03-27 |
| (30) | Number | Date | Country code |
| 826622 P | 2006-09-22 | US | |
| 828278 P | 2006-10-05 | US |
| (72) |
GATHMANN, Insa, CH
MAHON, Francois-Xavier, FR
MOLIMARD, Mathieu, FR
PICARD, Stéphane, FR
WANG, Yanfeng, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Filadelfijos chromosomą turinčių pacientų leukemijos gydymo optimizavimas ABL tirozinkinazės inhibitoriumi imatinibu |
| OPTIMIZATION OF THE TREATMENT OF PHILADELPHIA-POSITIVE LEUKEMIA WITH ABL TYROSINE KINASE INHIBITOR IMATINIB |
| Payment date | Validity (years) | Amount | |
| 2013-08-20 | 7 | 560.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-09-20 |